Clinical trial Recruiting at 2 sites Interventional Ages 21 to 50

Temporal interference stimulation for nicotine vaping addiction

Official title: Temporal Interference Methods for Addiction Treatment

Run by Indiana University · NCT07210268 · Data updated 2026-11-12

This trial will test whether a non-invasive brain stimulation method called temporal interference can lower cravings and reduce vaping in adults who use nicotine.

Quick facts

Study typeInterventional
Ages21 Years to 50 Years
SexAll
Enrollment120 (estimated)
SponsorIndiana University
Academic / other
Locations2 sites (Bloomington, Indiana and 1 other locations)
StatusRecruiting
StartedJanuary 22, 2026
Main results expectedFebruary 20, 2027
Study endsFebruary 27, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT07210268 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21–50 who are nicotine-dependent vapers (≥15 mg nicotine per day), can read English, have a phone with internet access, and can abstain from nicotine for at least 8 hours are the intended participants.

Probably not a fit

People with a history of seizures, active severe psychiatric or neurological disorders, significant cardiac problems, or active use of opioids, cocaine, or methamphetamine are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, placebo-controlled trial will enroll 120–150 nicotine-dependent adults who vape and randomize them to TI targeting the nucleus accumbens, TI targeting the anterior insula, or a sham condition. After at least 8 hours of nicotine abstinence, participants will undergo a single 60-minute stimulation session while using a custom vape device that records real-time inhalation and provide craving ratings during and after stimulation, with use monitored for one week. Temporal interference delivers intersecting high-frequency scalp currents that create a low-frequency envelope aimed at stimulating deep brain regions without surgery, and prior pilot work has shown TI can activate the nucleus accumbens on fMRI. The trial compares whether stimulation of the insula or nucleus accumbens reduces craving and nicotine inhalation more than sham.

Why it matters

Potential benefit: If successful, TI could offer a non-surgical way to rapidly reduce nicotine craving and vaping, potentially expanding treatment options for people who vape.

How similar studies have gone: Invasive deep brain stimulation of the nucleus accumbens and insula has produced strong reductions in addictive behavior in case reports, and pilot TI work shows target activation on fMRI, but TI for addiction remains novel and not yet proven in larger clinical trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 21 and 50
* Nicotine dependent and vape at least 15 mg nicotine per day
* Must have a phone with internet access
* Participants must have at least a 6th grade education and be able to speak and read English

Exclusion Criteria:

* History of seizures, seizure disorders, or familial history of seizure disorders
* History of intractable migraine or complicated migraine syndromes
* History of suicide attempts or active suicidal ideation (past month)
* History of cardiac arrhythmias, prolonged QT, pacemakers, or cardiovascular disorders
* Hypertension with systolic BP \>150mmHgCentral nervous system structural lesions (tumors, MS, strokes, etc.)
* Active neuropsychiatric disorders (schizophrenia, bipolar, active psychosis, dementia, etc.)
* History of head trauma with loss of consciousness, skull fractures, subdural hematomas
* Active opioid, cocaine, and/or methamphetamine use
* Active severe cannabis use disorder
* Active alcohol use disorder or history of alcohol withdrawal
* Metal implants in the head or under the scalp (excluding dental implants)
* Current smoking cessation treatment or medications affecting reward processing
* Pregnancy

Where it's running

  • Indiana University
    Bloomington, Indiana, United States
    Recruiting
  • Indiana University School of Medicine - Goodman Hall
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: Joshua Brown — Indiana University, Bloomington
  • Study coordinator: Joshua Brown, PhD
  • Email: cclab@iu.edu
  • Phone: 812-855-9282

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.